|
1 hit(s) found in 0.08 seconds Search term: BRUQQQPBMZOVGD-XFKAJCMBBP Found by InChIKey (full match)
Please
login
to be able to add spectra, identifiers, links and publications.
|
|
|
ChemSpider ID: |
4447649
|
|
Empirical Formula: |
C18H21NO4
|
|
Molecular Weight: |
315.3636
|
|
Nominal Mass: |
315
Da
|
|
Average Mass: |
315.3636
Da
|
|
Monoisotopic Mass: |
315.147058
Da
|
|
|
|
Systematic Name: |
|
|
SMILES: |
O=C4[C@@H]5Oc1c2c(ccc1OC)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)C
|
|
InChI: |
InChI=1/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1
|
|
InChIKey: |
BRUQQQPBMZOVGD-XFKAJCMBBP
|
|
Std. InChI: |
InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1
|
|
Std. InChIKey: |
BRUQQQPBMZOVGD-XFKAJCMBSA-N
|
Oxycodone is an opioid analgesic medication synthesized from opium-derived thebaine. It was developed in 1916 in Germany, as one of several new semi- synthetic opioids in an attempt to improve on the existing opiates and opioids: morphine, diacetylmorphine (heroin), and codeine.
Currently it is formulated as single ingredient products or compounded products. Some common examples of compounding are oxycodone with acetaminophen or NSAIDs such as ibuprofen. The formulations are available as generics but are also made under various brand names.
OxyContin is Purdue Pharma's brand for time-release single-ingredient oxycodone oral medication. The manufacturing rights to generic oxycodone time-release is under dispute.
Oxycodone oral medications are generally prescribed for the relief of moderate to severe pain.
Read more... or Edit at Wikipedia...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
(-)-Oxycodone
(1S,5R,13R,17S)-17-Hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0~1,13~.0~5,17~.0~7,18~]octadeca-7(18),8,10-trien-14-on
(1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0~1,13~.0~5,17~.0~7,18~]octadeca-7(18),8,10-trien-14-one
(1S,5R,13R,17S)-17-hydroxy-10-méthoxy-4-méthyl-12-oxa-4-azapentacyclo[9.6.1.0~1,13~.0~5,17~.0~7,18~]octadéca-7(18),8,10-trién-14-one
(5a)-4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
(5alpha)-14-hydroxy-17-methyl-3-(methyloxy)-4,5-epoxymorphinan-6-one
(5alpha)-14-Hydroxy-3-methoxy-17-methyl-4,5-epoxymorphinan-6-one
14-Hydroxydihydrocodeinone
200-960-2
[EINECS/ELINCS]
Eubine
More...
Eukodal
Eutagen
Morphinan-6-one, 4,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methyl-
Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)-
morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-
Oxicone
Oxikon
Oxycon
OXYCONTIN
[Wiki]
Tecodin
Tekodin
Thecodine
Thekodin
3-O-(Methyl)oxymorphone
6-Oxo-14-hydroxy-7,8-dihydrocodeine
7,8-Dihydro-14-hydroxycodeinone
COMBUNOX
Dihydrohydroxycondeinone
ENDOCET
Endodan
[Wiki]
OXYCET
Oxycodone [USAN:BAN:INN]
Oxymorphone 3-methyl ether
ROXILOX
149393
(-)-14-Hydroxydihydrocodeinone
124-90-3
[RN]
14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one
25333-72-6
[RN]
337376-15-5
[RN]
4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
4-27-00-03681 (Beilstein Handbook Reference)
[Beilstein]
43446
[Beilstein]
76-42-6
[RN]
Codeinone, 7,8-dihydro-14-hydroxy-
Codeinone, dihydro-14-hydroxy-
Codeinone, dihydrohydroxy-
Dihydro-14-hydroxycodeinone
Dihydrohydroxycodeinone
[Wiki]
Dihydrone
Dihydroxycodeinone
Dinarkon
Diphydrone
Endine (Australia)
Endone
Eubine [France]
Eucodal
[Wiki]
Eucodalum
Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-
Morphinan-6-one, 4,5-alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-
Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl- (8CI)
Ossicodone [DCIT]
Oxanest
oxicodona
[Spanish]
Oxicodona [INN-Spanish]
Oxicon
Oxycodeinone
Oxycodon
oxycodone
[Wiki]
oxycodone hydrochloride
oxycodonum
[Latin]
Oxycodonum [INN-Latin]
Pancodine
Pancodone retard (United Kingdom)
Percobarb
PERCOCET
[Wiki]
PERCODAN
[Wiki]
ROXICET
[Wiki]
ROXICODONE
[Wiki]
Supendol [Canada]
Tekodin (free base)
TYLOX
[Wiki]
Less...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
|
ACD/LogP: |
1.67
|
# of Rule of 5 Violations: |
0
|
|
ACD/LogD (pH 5.5): |
-0.47
|
ACD/LogD (pH 7.4): |
1.21
|
|
ACD/BCF (pH 5.5): |
1
|
ACD/BCF (pH 7.4): |
3.76
|
|
ACD/KOC (pH 5.5): |
1.42
|
ACD/KOC (pH 7.4): |
66.4
|
|
#H bond acceptors: |
5
|
#H bond donors: |
1
|
|
#Freely Rotating Bonds: |
2
|
Polar Surface Area: |
48
Å2
|
|
Index of Refraction: |
1.659
|
Molar Refractivity: |
83.11
cm3
|
|
Molar Volume: |
225.3
cm3
|
Polarizability: |
32.95
10-24cm3
|
|
Surface Tension: |
64.5
dyne/cm
|
Density: |
1.39
g/cm3
|
|
Flash Point: |
257.1
°C
|
Enthalpy of Vaporization: |
81.13
kJ/mol
|
|
Boiling Point: |
501.6
°C at 760 mmHg
|
Vapour Pressure: |
7.02E-11
mmHg at 25°C
|
Log Octanol-Water Partition Coef (SRC):
Log Kow (KOWWIN v1.67 estimate) = 0.66
Boiling Pt, Melting Pt, Vapor Pressure Estimations (MPBPWIN v1.42):
Boiling Pt (deg C): 428.75 (Adapted Stein & Brown method)
Melting Pt (deg C): 179.32 (Mean or Weighted MP)
VP(mm Hg,25 deg C): 2.22E-010 (Modified Grain method)
MP (exp database): 219 deg C
Subcooled liquid VP: 2.62E-008 mm Hg (25 deg C, Mod-Grain method)
Water Solubility Estimate from Log Kow (WSKOW v1.41):
Water Solubility at 25 deg C (mg/L): 2.764e+004
log Kow used: 0.66 (estimated)
no-melting pt equation used
Water Sol Estimate from Fragments:
Wat Sol (v1.01 est) = 6420.2 mg/L
ECOSAR Class Program (ECOSAR v0.99h):
Class(es) found:
Aliphatic Amines
Henrys Law Constant (25 deg C) [HENRYWIN v3.10]:
Bond Method : 2.33E-016 atm-m3/mole
Group Method: Incomplete
Henrys LC [VP/WSol estimate using EPI values]: 3.333E-015 atm-m3/mole
Log Octanol-Air Partition Coefficient (25 deg C) [KOAWIN v1.10]:
Log Kow used: 0.66 (KowWin est)
Log Kaw used: -14.021 (HenryWin est)
Log Koa (KOAWIN v1.10 estimate): 14.681
Log Koa (experimental database): None
Probability of Rapid Biodegradation (BIOWIN v4.10):
Biowin1 (Linear Model) : 0.3496
Biowin2 (Non-Linear Model) : 0.0746
Expert Survey Biodegradation Results:
Biowin3 (Ultimate Survey Model): 1.6096 (recalcitrant)
Biowin4 (Primary Survey Model) : 2.8613 (weeks )
MITI Biodegradation Probability:
Biowin5 (MITI Linear Model) : 0.3979
Biowin6 (MITI Non-Linear Model): 0.0911
Anaerobic Biodegradation Probability:
Biowin7 (Anaerobic Linear Model): -1.8160
Ready Biodegradability Prediction: NO
Hydrocarbon Biodegradation (BioHCwin v1.01):
Structure incompatible with current estimation method!
Sorption to aerosols (25 Dec C)[AEROWIN v1.00]:
Vapor pressure (liquid/subcooled): 3.49E-006 Pa (2.62E-008 mm Hg)
Log Koa (Koawin est ): 14.681
Kp (particle/gas partition coef. (m3/ug)):
Mackay model : 0.859
Octanol/air (Koa) model: 118
Fraction sorbed to airborne particulates (phi):
Junge-Pankow model : 0.969
Mackay model : 0.986
Octanol/air (Koa) model: 1
Atmospheric Oxidation (25 deg C) [AopWin v1.92]:
Hydroxyl Radicals Reaction:
OVERALL OH Rate Constant = 242.9487 E-12 cm3/molecule-sec
Half-Life = 0.044 Days (12-hr day; 1.5E6 OH/cm3)
Half-Life = 0.528 Hrs
Ozone Reaction:
No Ozone Reaction Estimation
Fraction sorbed to airborne particulates (phi): 0.977 (Junge,Mackay)
Note: the sorbed fraction may be resistant to atmospheric oxidation
Soil Adsorption Coefficient (PCKOCWIN v1.66):
Koc : 114.9
Log Koc: 2.060
Aqueous Base/Acid-Catalyzed Hydrolysis (25 deg C) [HYDROWIN v1.67]:
Rate constants can NOT be estimated for this structure!
Bioaccumulation Estimates from Log Kow (BCFWIN v2.17):
Log BCF from regression-based method = 0.500 (BCF = 3.162)
log Kow used: 0.66 (estimated)
Volatilization from Water:
Henry LC: 2.33E-016 atm-m3/mole (estimated by Bond SAR Method)
Half-Life from Model River: 4.462E+012 hours (1.859E+011 days)
Half-Life from Model Lake : 4.868E+013 hours (2.028E+012 days)
Removal In Wastewater Treatment:
Total removal: 1.86 percent
Total biodegradation: 0.09 percent
Total sludge adsorption: 1.77 percent
Total to Air: 0.00 percent
(using 10000 hr Bio P,A,S)
Level III Fugacity Model:
Mass Amount Half-Life Emissions
(percent) (hr) (kg/hr)
Air 2.42e-007 1.06 1000
Water 50.6 4.32e+003 1000
Soil 49.3 8.64e+003 1000
Sediment 0.104 3.89e+004 0
Persistence Time: 1.6e+003 hr
Descriptors:
0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 1, 2, 8, 2, 10, 0, 6, 0, 1, 1, 0, 0, 0, 0
| Category | Target | PDB Code | LASSO Score |
| Nuclear Hormone Receptors | PPARg, peroxisome proliferator activated receptor | 1fm9 | 0.03 |
| Kinases | PDGFrb, platelet derived growth factor receptor kinase | N/A | 0.02 |
| Kinases | TK, thymidine kinase | 1kim | 0.02 |
| Kinases | SRC, tyrosine kinase SRC | 2src | 0.01 |
| Other Enzymes | HMGR, hydroxymethylglutaryl-CoA reductase | 1hw8 | 0.01 |
| Other Enzymes | HIVPR, HIV protease | 1hpx | 0.01 |
| Kinases | HSP90, human heat shock protein 90 | 1uy6 | 0.01 |
| Metalloenzymes | PDE5, phosphodiesterase 5 | 1xp0 | 0.01 |
| Nuclear Hormone Receptors | MR, mineralocorticoid receptor | 2aa2 | 0.01 |
| Other Enzymes | PARP, poly(ADP-ribose) polymerase | 1efy | 0.01 |
| Other Enzymes | PNP, purine nucleoside phosphorylase | 1b8o | 0.00 |
| Other Enzymes | AmpC, AmpC beta-lactamase | 1xgj | 0.00 |
| Nuclear Hormone Receptors | ER, estrogen receptor; agonist | 1l2i | 0.00 |
| Other Enzymes | SAHH, S-adenosyl-homocysteine hydrolase | 1a7a | 0.00 |
| Nuclear Hormone Receptors | GR, glucocorticoid receptor | 1m2z | 0.00 |
| Folate Enzymes | DHFR, dihydrofolate reductase | 3dfr | 0.00 |
| Metalloenzymes | ADA, adenosine deaminase | 1stw | 0.00 |
| Kinases | VEGFr2, vascular endothelial growth factor receptor | 1vr2 | 0.00 |
| Other Enzymes | GPB, glycogen phosphorylase | 1a8i | 0.00 |
| Other Enzymes | AChE, acetylcholinesterase | 1eve | 0.00 |
| Kinases | FGFr1, fibroblast growth factor receptor kinase | 1agw | 0.00 |
| Serine Proteases | Thrombin | 1ba8 | 0.00 |
| Other Enzymes | InhA, enoyl ACP reductase | 1p44 | 0.00 |
| Nuclear Hormone Receptors | RXRa, retinoic X receptor R | 1mvc | 0.00 |
| Other Enzymes | ALR2, aldose reductase | 1ah3 | 0.00 |
| Folate Enzymes | GART, glycinamide ribonucleotide transformylase | 1c2t | 0.00 |
| Metalloenzymes | ACE, angiotensin-converting enzyme | 1o86 | 0.00 |
| Nuclear Hormone Receptors | AR, androgen receptor | 1xq2 | 0.00 |
| Kinases | P38 MAP, P38 mitogen activated protein | 1kv2 | 0.00 |
| Nuclear Hormone Receptors | ER, estrogen receptor; antagonist | 3ert | 0.00 |
| Other Enzymes | NA, neuraminidase | 1a4g | 0.00 |
| Other Enzymes | HIVRT, HIV reverse transcriptase | 1rt1 | 0.00 |
| Kinases | EGFr, epidermal growth factor receptor | 1m17 | 0.00 |
| Serine Proteases | FXa, factor Xa | 1f0r | 0.00 |
| Kinases | CDK2, cyclindependent kinase 2 | 1ckp | 0.00 |
| Metalloenzymes | COMT, catechol O-methyltransferase | 1h1d | 0.00 |
| Other Enzymes | COX-1, cyclooxygenase-1 | 1p4g | 0.00 |
| Other Enzymes | COX-2, cyclooxygenase-2 | 1cx2 | 0.00 |
| Serine Proteases | Trypsin | 1bju | 0.00 |
|
|